Goldman Sachs’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History
Bought
Maintained
Sold
Other funds holding AONC
GCL
SCM
PC
WAM
MMA
Goldman Sachs's AONC Position: Q3 2022 in Review
Goldman Sachs sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q3 2022, closing a stake of 754,647 shares — an estimated $7.38M sold.
Goldman Sachs first reported a position in AONC in Q2 2021 and held it in 5 quarters. The position peaked at $7.38M in Q2 2022. 74 funds tracked by Wall St. Rank hold AONC as of Q3 2022.
- Goldman Sachs reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
- Goldman Sachs sold 754,647 American Oncology Network, Inc. Class A Common Stock shares in Q3 2022, an estimated $7.38M.
- Goldman Sachs first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 5 quarters.
- Goldman Sachs's American Oncology Network, Inc. Class A Common Stock position peaked at $7.38M in Q2 2022.
- 74 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q3 2022.
Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.